HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease.

AbstractBACKGROUND & AIMS:
Plasma soluble E-selectin (sE-selectin) is a frequently used biomarker of systemic endothelial dysfunction. The present study explored the relationship between nonalcoholic fatty liver disease (NAFLD) and plasma sE-selectin levels.
METHODS:
Expression of E-selectin in liver, visceral adipose tissue (VAT) and muscle was studied in relation to plasma sE-selectin in severely obese individuals (n = 74). The course of hepatic E-selectin expression in relation to hepatic steatosis and inflammation was examined in C57BL/6J LDLR-/- mice on a Western-type diet. The relationship between biomarkers of NAFLD, that is, plasma aminotransferase (ALT) and NAFLD susceptibility genes (rs738409 [PNPLA3] and rs1260326 [GCKR]), and plasma sE-selectin was studied in the combined CODAM (n = 571) and Hoorn (n = 694) studies.
RESULTS:
E-selectin expression in liver, not VAT or muscle, was associated with plasma sE-selectin in severely obese individuals (β = 0.26; 95% CI: 0.05-0.47). NAFLD severity was associated with hepatic E-selectin expression (P = .02) and plasma sE-selectin (P = .003). LDLR-/- mice on a Western-type diet displayed increased hepatic E-selectin expression that followed the same course as hepatic inflammation, but not steatosis. In the CODAM study, plasma ALT was associated with plasma sE-selectin, independent of potential confounders (β = 0.25; 95% CI: 0.16-0.34). Both rs738409 and rs1260326 were associated with higher plasma sE-selectin in the combined CODAM and Hoorn studies (P = .01 and P = .004 respectively).
CONCLUSIONS:
NAFLD and related markers are associated with higher expression of hepatic E-selectin and higher levels of plasma sE-selectin. Further studies are required to investigate the role of E-selectin in the pathogenesis of NAFLD and the applicability of sE-selectin as a plasma biomarker of NAFLD/NASH.
AuthorsNynke Simons, Mitchell Bijnen, Kristiaan A M Wouters, Sander S Rensen, Joline W J Beulens, Marleen M J van Greevenbroek, Leen M 't Hart, Jan Willem M Greve, Carla J H van der Kallen, Nicolaas C Schaper, Casper G Schalkwijk, Coen D A Stehouwer, Martijn C G J Brouwers
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 40 Issue 5 Pg. 1079-1088 (05 2020) ISSN: 1478-3231 [Electronic] United States
PMID31960587 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2020 The Authors. Liver International published by John Wiley & Sons Ltd.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Biomarkers
  • Cadherins
  • Cdh1 protein, mouse
  • Gckr protein, mouse
  • Lipase
  • PNPLA3 protein, mouse
  • Phospholipases A2, Calcium-Independent
Topics
  • Adaptor Proteins, Signal Transducing
  • Animals
  • Biomarkers
  • Cadherins (genetics)
  • Lipase
  • Liver
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease (genetics)
  • Phospholipases A2, Calcium-Independent

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: